Skip to main content

Birchview Capital, LP

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1618205 BURLINGTON, VT

Position in ZNTL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$40,957
+$18,007 QoQ
Shares Held
17,503
+3.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Birchview Capital, LP holds $86,547,277 across 48 Biotechnology names. ZNTL ranks #47 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ZNTL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $40,957 17,503
2025-12-31 $22,950 17,000
2025-09-30 $25,670 17,000
2025-06-30 $19,720 17,000
2025-03-31 $27,030 17,000
2024-12-31 $51,510 17,000
2024-09-30 $58,880 16,000
2024-06-30 $65,440 16,000
2024-03-31 $252,160 16,000
2023-12-31 $242,400 16,000
2022-06-30 $224,800 8,000
2022-03-31 $369,120 8,000
2021-12-31 $672,480 8,000
2021-09-30 $533,120 8,000
2021-06-30 $425,600 8,000